Arbutus Biopharma ABUS offers expected to start Aug 24, 2026
Arbutus Biopharma Corp says a cash offer is expected to commence on or about August 24, 2026, with a purchase price of not less than US$5.00 and not more than US$5.75 per share.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.